Literature DB >> 8967502

Mechanism of ATP-induced leukocyte adherence to cultured pulmonary artery endothelial cells.

A L Parker1, L L Likar, D D Dawicki, S Rounds.   

Abstract

Previously we have shown that ATP enhances the adherence of HL-60 cells and human neutrophils to bovine pulmonary artery endothelial cells. The current investigations extend earlier findings by showing that ATP and UTP dose-dependently stimulate human neutrophil adherence to human pulmonary artery endothelial cells. We have also explore the mechanisms of ATP- and UTP-stimulated adherence. We have found that fucose, a component of selectin receptors, inhibits ATP-stimulated HL-60 cell-bovine pulmonary artery endothelial cell adhesion. Additionally, pretreatment of HL-60 cells with neuraminidase abolishes ATP enhancement. However, fucose does not affect ATP- or thrombin-induced adhesion of freshly isolated human neutrophils to human endothelial cells. Antibodies to human P-selection intercellular adhesion molecule (ICAM)-1, and the beta-subunit of CD11/CD18 do not alter ATP-induced adherence of HL-60 cells to bovine endothelial cells. Similarly, antibodies to human P-selectin and ICAM-1 do not inhibit human neutrophil-human pulmonary artery endothelial cell adhesion. The platelet-activating factor receptor antagonists, WEB-2086 and L-659,989, are effective in attenuating ATP- and UTP-stimulated adherence. Preincubation of neutrophils or human pulmonary artery endothelial cells with ATP or UTP also enhances adherence, an effect that is blocked by L-659,989. Thus platelet activating factor, associated with both neutrophils and endothelial cells, mediates ATP- and UTP-induced neutrophil adherence. ATP, released during vascular injury, may exacerbate neutrophil-endothelial cell interaction and thereby contribute to neutrophil-induced injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967502     DOI: 10.1152/ajplung.1996.270.5.L695

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line.

Authors:  Olga J Baker; Jean M Camden; Danny E Rome; Cheikh I Seye; Gary A Weisman
Journal:  Mol Immunol       Date:  2007-06-27       Impact factor: 4.407

2.  Expression and functional characterization of P2X receptors in mouse alveolar macrophages.

Authors:  Sarah Kessler; Wolfgang G Clauss; Andreas Günther; Wolfgang Kummer; Martin Fronius
Journal:  Pflugers Arch       Date:  2011-06-03       Impact factor: 3.657

Review 3.  P2Y2 nucleotide receptor-mediated responses in brain cells.

Authors:  Troy S Peterson; Jean M Camden; Yanfang Wang; Cheikh I Seye; W G Wood; Grace Y Sun; Laurie Erb; Michael J Petris; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2010-04-13       Impact factor: 5.590

Review 4.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

5.  An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction.

Authors:  L Erb; J Liu; J Ockerhausen; Q Kong; R C Garrad; K Griffin; C Neal; B Krugh; L I Santiago-Pérez; F A González; H D Gresham; J T Turner; G A Weisman
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

6.  Signaling pathways downstream of P2 receptors in human neutrophils.

Authors:  John Meshki; Florin Tuluc; Ovidiu Bredetean; Analia Garcia; Satya P Kunapuli
Journal:  Purinergic Signal       Date:  2006-06-20       Impact factor: 3.765

7.  P2 receptors in atherosclerosis and postangioplasty restenosis.

Authors:  Cheikh I Seye; Qiongman Kong; Ningpu Yu; Fernando A Gonzalez; Laurie Erb; Gary A Weisman
Journal:  Purinergic Signal       Date:  2006-06-14       Impact factor: 3.765

8.  P2 receptors in atherosclerosis and postangioplasty restenosis.

Authors:  Cheikh I Seye; Qiongman Kong; Ningpu Yu; Fernando A Gonzalez; Laurie Erb; Gary A Weisman
Journal:  Purinergic Signal       Date:  2007-02-28       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.